ArticleThe Journal of infectious diseases2018

A Herpes Simplex Virus (HSV)-2 Single-Cycle Candidate Vaccine Deleted in Glycoprotein D Protects Male Mice From Lethal Skin Challenge With Clinical Isolates of HSV-1 and HSV-2.

Clare Burn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.